The stock declined 1.25% or $1.43 reaching $112.98 per share ... Employees …
(NYSE:BAX) by 29.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 649,708 shares of the medical instruments supplier's stock after selling …
The Sr VP, President, Americas now owns $2,529,217 of the stock as recorded in a recent Form 4 SEC filing. Thomas T. Stallkamp, Director disclosed the sale of 10,698 shares of (BAX). The shares were sold on May 5th for an average price …
Weaver C Barksdale & Associates Inc who had been investing in Novartis A G for a number of months, seems to be bullish on the $208.82 billion market cap company. The Company operates through two segments: Hospital Products and …
B-stock items are offered at a lower price than the brand-new products in our web shop, which can save you quite a bit of money! A B-stock product cannot be sold as new any more. Sometimes the packaging has been opened or damaged, …
Headquartered in Deerfield, IL, Baxter International Inc. (NYSE:BAX) , a global medical technology company, announced a new oral health project in collaboration with Americares, a health-focused relief and development organization. Notably, …
Almeida. For a complete fundamental analysis analysis of Baxter International Inc., check out Equities.com’s Stock Valuation Analysis report for BAX.
NYSE New 52 Week Highs – JEQ, MITT, AMX, AMOV, APH, AME, ARR, BCH, BAX, BDJ, BUI, BOX, BR, CTLT, CO, …
Baxter expects “when-issued” trading for both Baxter and Baxalta to begin on the NYSE on June 15, 2015 under the …